| Advantages | They are ideal for cancer biology research, drug sensitivity testing, and precision medicine applications. |
| Species | Human |
| Product Type | Tissue-derived Organoid |
| Growth Properties | Embedded 3D Culture |
| Growth Conditions | Cultured at 37°C under 95% air and 5% CO2. |
| Quality Control | Negative for mycoplasma, bacteria, yeast, and fungi. |
| Tissue | Bladder |
| Disease | Cancer |
| Format | Frozen |
| Organoid Characterization | Validated through histopathology (H&E and IHC), stable multi-generational passaging, xenograft tumor formation (PDOX), and comprehensive NGS profiling, these organoids provide a physiologically relevant platform for studying tumor heterogeneity, invasion mechanisms, resistance pathways, and therapeutic responses. |
| Applications | Tissue-derived organoids are widely utilized in drug screening, disease modeling, mechanistic studies, personalized medicine, and regenerative medicine. By accurately modeling disease states, they provide a robust platform for evaluating patient-specific drug responses and supporting individualized treatment planning. Moreover, these organoids enable the development of new therapeutic modalities, particularly in cancer research and tissue regeneration, delivering precise experimental systems that significantly advance precision medicine. |
| Storage | Liquid Nitrogen |
| Shipping Information | Dry Ice |
For preclinical research and development use only; not intended for therapeutic or other applications.
Alfa Cytology is a preclinical research service provider specializing in tumor organoid development. We provide one-stop services that include tailored 3D cancer models, organoid-based research services, and related products to accelerate the discovery and development of cancer therapeutics.
Copyright © 2026 Alfa Cytology. All rights reserved.